×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NTRA – natera, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NTRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
08:00 am
ntra
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
Low
Report
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
12/10
08:52 pm
ntra
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer [Yahoo! Finance]
Low
Report
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer [Yahoo! Finance]
12/10
07:57 pm
ntra
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer
Low
Report
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer
12/9
08:00 am
ntra
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
Low
Report
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
12/8
01:20 pm
ntra
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $250.00 price target on the stock.
Low
Report
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $250.00 price target on the stock.
12/8
08:07 am
ntra
Natera (NASDAQ:NTRA) had its price target raised by analysts at BTIG Research from $230.00 to $260.00. They now have a "buy" rating on the stock.
Low
Report
Natera (NASDAQ:NTRA) had its price target raised by analysts at BTIG Research from $230.00 to $260.00. They now have a "buy" rating on the stock.
12/5
07:00 am
ntra
Natera Acquires Foresight Diagnostics
Low
Report
Natera Acquires Foresight Diagnostics
12/3
08:00 am
ntra
New Signatera™ Data in Lymphoma and Multiple Myeloma to be Presented at the 2025 American Society of Hematology Annual Meeting
Low
Report
New Signatera™ Data in Lymphoma and Multiple Myeloma to be Presented at the 2025 American Society of Hematology Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/12
05:17 pm
ntra
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
Neutral
Report
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
12/12
10:07 am
ntra
Form 144 Natera, Inc. Filed by: ROSENMAN HERM
Low
Report
Form 144 Natera, Inc. Filed by: ROSENMAN HERM
12/11
08:35 pm
ntra
Form 4 Natera, Inc. For: Dec 09 Filed by: Sheena Jonathan
Low
Report
Form 4 Natera, Inc. For: Dec 09 Filed by: Sheena Jonathan
12/9
08:35 pm
ntra
Form 4 Natera, Inc. For: Dec 05 Filed by: Chapman Rowan E
Low
Report
Form 4 Natera, Inc. For: Dec 05 Filed by: Chapman Rowan E
12/8
09:55 pm
ntra
Form 4 Natera, Inc. For: Dec 04 Filed by: RABINOWITZ DANIEL
Low
Report
Form 4 Natera, Inc. For: Dec 04 Filed by: RABINOWITZ DANIEL
12/5
07:26 pm
ntra
Form 144 Natera, Inc. Filed by: Chapman Rowan E
Low
Report
Form 144 Natera, Inc. Filed by: Chapman Rowan E
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Natera Provides Remote Access to Tests Without Requiring Live Office Visits
39.3%
5/9 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.590 ActVsEst 0.050 - Beat 22.3%
8/7 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.570 ActVsEst 0.090 - Beat 17.7%
4/6 Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives 11.2%
3/4 Form S-8 Natera, Inc. 9.9%
3/12 Form 8-K Natera, Inc. For: Mar 06 8.8%
1/15 Form 4 Natera, Inc. For: Jan 13 Filed by: Rabinowitz Matthew 7.6%
2/26 Q4/2019 12/31/2019 EPS -0.460 ZacksConsensus -0.600 ActVsEst 0.140 - Beat 7.1%
8/22 Panorama NIPT Achieves 2 Million Test Milestone 6.6%
9/11 Form 4 Natera, Inc. For: Sep 09 Filed by: Brophy Michael Burkes 6.4%
5/9 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.590 ActVsEst 0.050 - Beat 22.3%
8/7 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.570 ActVsEst 0.090 - Beat 17.7%
4/6 Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives 11.2%
3/4 Form S-8 Natera, Inc. 9.9%
3/12 Form 8-K Natera, Inc. For: Mar 06 8.8%
1/15 Form 4 Natera, Inc. For: Jan 13 Filed by: Rabinowitz Matthew 7.6%
2/26 Q4/2019 12/31/2019 EPS -0.460 ZacksConsensus -0.600 ActVsEst 0.140 - Beat 7.1%
8/22 Panorama NIPT Achieves 2 Million Test Milestone 6.6%
9/11 Form 4 Natera, Inc. For: Sep 09 Filed by: Brophy Michael Burkes 6.4%
TOP News Decliners
8/5
Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies
-14.6%
3/6 Natera, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -13.1%
3/31 Form 4 Natera, Inc. For: Mar 27 Filed by: Rabinowitz Matthew -12.7%
3/11 Form 4 Natera, Inc. For: Mar 09 Filed by: Chapman Steven Leonard -8.7%
3/18 Form SEC STAFF LETTER Natera, Inc. -8.4%
4/13 Natera Announces Preliminary First Quarter 2020 Financial Results -7.8%
8/13 Form 4 Natera, Inc. For: Aug 09 Filed by: BOTHA ROELOF -7.7%
9/6 Form 4 Natera, Inc. For: Sep 04 Filed by: Brophy Michael Burkes -7.6%
10/15 Form S-3ASR Natera, Inc. -7.4%
2/27 Natera Inc (NASDAQ: NTRA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $49.00 price target on the stock, up previously from $45.00. -5.6%
3/6 Natera, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -13.1%
3/31 Form 4 Natera, Inc. For: Mar 27 Filed by: Rabinowitz Matthew -12.7%
3/11 Form 4 Natera, Inc. For: Mar 09 Filed by: Chapman Steven Leonard -8.7%
3/18 Form SEC STAFF LETTER Natera, Inc. -8.4%
4/13 Natera Announces Preliminary First Quarter 2020 Financial Results -7.8%
8/13 Form 4 Natera, Inc. For: Aug 09 Filed by: BOTHA ROELOF -7.7%
9/6 Form 4 Natera, Inc. For: Sep 04 Filed by: Brophy Michael Burkes -7.6%
10/15 Form S-3ASR Natera, Inc. -7.4%
2/27 Natera Inc (NASDAQ: NTRA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $49.00 price target on the stock, up previously from $45.00. -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: